Glenmark Pharmaceuticals

Coronavirus Outbreak Updates: Confirmed cases in Mumbai surge to 66,507 as city reports 1,242 new infections; toll rises to 3,669 with 41 deaths

Coronavirus Outbreak Updates: Mumbai on Sunday recorded 1,242 new coronavirus positive cases and 41 deaths, taking the total positive cases to 66,507 and toll to 3,669.

Glenmark Pharmaceuticals receives approval from USFDA to market generic drug for muscle pain in American market

Glenmark Pharmaceuticals on Wednesday said its subsidiary has received approval from the US health regulator to market Chlorzoxazone tablets, used to treat muscle pain, in the American market

Glenmark to study potential COVID-19 drug combination; to look to enroll 158 hospitalised patients

On 1 May, Glenmark Pharmaceuticals said it has become the first company in India to receive approval from Drug Controller General of India (DCGI) to conduct clinical trials of Favipiravir antiviral tablets for the treatment of COVID-19 patients.

Strides Pharma receives regulatory approval to conduct trials in India for potential COVID-19 drug

Indian pharmaceutical company Strides Pharma Science Ltd said on Thursday it has got regulatory approval to conduct clinical trials of antiviral drug favipiravir, considered a potential treatment for COVID-19

Glenmark to conduct trials for potential COVID-19 drug, first company in India to receive DCGI approval; shares jump 9%

Glenmark filed the product for clinical trials with the DCGI and has received approval for conducting the trial on mild to moderate patients, said the BSE filing.

Glenmark Pharmaceuticals shares plunge 10% to hit 52-week low on USFDA warning letter

Shares of Glenmark Pharmaceuticals tumbled nearly 10 percent and hit its 52-week low level on the bourses on Monday after the company received a warning letter from the US health regulator for its Baddi facility in Himachal Pradesh

Glenmark Q4 net profit up 6.62% at Rs 162 cr; board approves raising funds up to $200 mn through debt securities

Glenmark Pharma's consolidated revenue for 2018-19 stood at Rs 9,865.46 crore, compared to Rs 9,103.07 crore in the preceding fiscal.

Glenmark signs licence deal with Harbour BioMed to commercialise cancer antibody in Greater China

Glenmark will receive an upfront payment and is eligible to receive payments for achieving pre-specified development, regulatory and commercialisation milestones

How Enterprise Mobility Can Transform Pharma

Mohar Tiwari, VP- IT, Glenmark Pharmaceuticals points out that email, Salesforce automation solutions are best suited to be ported to the mobility framework for the pharmaceutical sector.

CCEA clears Glenmark, Aurobindo foreign funding proposals worth Rs 4,187 cr

The decision was taken by the Cabinet Committee on Economic Affairs, chaired by Prime Minister Narendra Modi.